<div id="readability-page-1">NeoGenomics (NASDAQ:NEO) is scheduled to announce Q2 earnings results on Tuesday, July 29th, before market open. The consensus EPS Estimate is $0.02 (-33.3% Y/Y) and the consensus Revenue Estimate is $182.64M (+10.7% Y/Y). Over the last 2 years, NEO has beaten EPS estimates 100% of the time and has beaten revenue estimates 75% of the time. Over the...</div>

<p>NeoGenomics（納斯達克代碼：NEO）將於 7 月 29 日公佈其第二季度財報，市場普遍預期每股收益（EPS）為 0.02 美元，同比下降 33.3%；預計收入為 1.8264 億美元，同比增加 10.7%。該公司在過去兩年中表現出色，100% 超出每股收益預期，75% 超出收入預期</p>

Neogenomics 2025 年第二季度財報預覽